SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010823
Filing Date
2019-11-12
Accepted
2019-11-12 16:35:16
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20190930x10q.htm 10-Q 1615649
2 EX-31.1 aptx-20190930ex311e010d3.htm EX-31.1 24027
3 EX-31.2 aptx-20190930ex312647ecd.htm EX-31.2 24043
4 EX-32.1 aptx-20190930ex321eddf4e.htm EX-32.1 16545
  Complete submission text file 0001558370-19-010823.txt   5166331

Data Files

Seq Description Document Type Size
5 EX-101.INS aptx-20190930.xml EX-101.INS 1041458
6 EX-101.SCH aptx-20190930.xsd EX-101.SCH 31535
7 EX-101.CAL aptx-20190930_cal.xml EX-101.CAL 32364
8 EX-101.DEF aptx-20190930_def.xml EX-101.DEF 133172
9 EX-101.LAB aptx-20190930_lab.xml EX-101.LAB 274216
10 EX-101.PRE aptx-20190930_pre.xml EX-101.PRE 243415
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 191210111
SIC: 2834 Pharmaceutical Preparations